Abstract 36: Application of patients derived organoids as co-clinical model
| Autor: | Sang-Hyun Song, Young-Won Cho, Sae-Won Han, Dong Wook Min, Hwang-Phill Kim, Yoojoo Lim, Tae-You Kim |
|---|---|
| Rok vydání: | 2019 |
| Předmět: | |
| Zdroj: | Cancer Research. 79:36-36 |
| ISSN: | 1538-7445 0008-5472 |
| Popis: | Organoids are known to best in vitro model system which mostly mimic genetic, phenotypic feature of its origin. And it is expected and suitable to variable disease modeling and study. For cancer modeling using organoids as co-clinical model, our group derived organoids from 40 colorectal tumor including lymph node, terminal ileum metastatic tumor and ascites. Whole exome sequencing of matched tumor organoids and tissues was performed and their somatic mutation concordance was analyzed. As a results, Organoids reflect their genetic statues of the original tumor tissue and their phenotypic features are maintained. In order to prove the appliance of these organoids as a co-clinical model, clinical drugs on colorectal cancer such as 5-Fluorouracil, oxaliplatin, SN38 and cetuximab were tested. The drug results reflected the actual clinical outcome of the corresponding patients. To find the precise drug treatment option for conventional chemo-refractory patients, we performed 134 anti-cancer drug library screening. Organoids with specific mutations were sensitive to drugs which target these corresponding mutations. For instance, organoid with RNF43 mutation was sensitive to porcupine inhibitor which suppresses auto- and paracrine WNT- driven growth. In conclusion, we suggest that patient derived organoids can be applied in cancer treatment as a co-clinical model, due to their highly correlated genetic information and drug sensitivity with those of the patients themselves. Citation Format: Young-Won Cho, Hwang-Phill Kim, Dong Wook Min, Yoojoo Lim, Sang-Hyun Song, Sae-Won Han, Tae-You Kim. Application of patients derived organoids as co-clinical model [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 36. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|